Study #ID01-022
USE OF THE CA 125 ALGORITHM FOR THE EARLY DETECTION OF OVARIAN CANCER IN LOW RISK WOMEN
MD Anderson Study Status
Enrolling
Treatment Agent
Description
The goal of this clinical research study is to evaluate a method involving 4 blood tests called CA-125, HE4, HE4 antigen autoantibody complexes, and osteopontin that may be helpful in the early detection of ovarian cancer in women who are at low risk.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Ovarian Cancer
Study phase:
Not applicable
Physician name:
Denise Nebgen
Department:
Gynecologic Oncology & Reproductive Medicine
For general questions about clinical trials:
1-844-241-7617
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.